Showing results (311-320 of 702) with videos related to

Sort By:
Pageof 71
Archives of Osteoporosis|May 3, 2018
Long-term benefits and risks of parathyroid hormone treatment in compliant osteoporotic patients. A Danish national register based cohort studyAnne-Luise Thorsteinsson, Louise Hansen, Peter Vestergaard, et al.
Bone|November 29, 2016
Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetesJakob Starup-Linde, Søren Gregersen, Morten Frost, et al.
Acta Diabetologica|November 23, 2019
Association of severe hypoglycemia with mortality for people with diabetes mellitus during a 20-year follow-up in Denmark: a cohort studyMorten Hasselstrøm Jensen, Claus Dethlefsen, Ole Hejlesen, et al.
Ugeskrift for Laeger|October 9, 2014
[Denosumab normalized plasma calcium concentration in malignancy-associated hypercalcaemia]Louise Størling, Gerda Elisabeth Villadsen, Klaus Krogh, et al.
Ugeskrift for Laeger|December 15, 2015
[Diabetes increases the risk of fractures]Jakob Starup-Linde, Azra Karahasanovic, Peter Vestergaard, et al.
Pediatrics|November 5, 2002
Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover studyClaus Højbjerg Gravholt, Rune Weis Naeraa, Kim Brixen, et al.
European Journal of Endocrinology|July 11, 2015
European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adultsJens Bollerslev, Lars Rejnmark, Claudio Marcocci, et al.
Clinical Endocrinology|February 20, 2024
Hypoparathyroidism and mortality after total thyroidectomy: A nationwide matched cohort studyRasmus Reinke, Sebastian Udholm, Christian Fynbo Christiansen, et al.
Clinical Case Reports|October 21, 2016
Multiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3Silje Hovden, Marie Louise Jespersen, Peter H Nissen, et al.
Clinical Endocrinology|May 8, 2018
Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trialLise Sofie Bislev, Lene Langagergaard Rødbro, Jesper Nørgaard Bech, et al.
Pageof 71